Healthcare resource utilization among patients with Sickle Cell Disease with recurrent vaso-occlusive crises in Germany

被引：0
|
作者：
Tuzin, P. [1 ]
Udeze, C. [2 ]
Kunzweiler, C. [2 ]
Li, N. [2 ]
Baldwin, J. [2 ]
Barth, S. D. [3 ]
Vetter, C. [3 ]
Dombrowski, S. [3 ]
Georgiadou-Schmidt, E. [4 ]
Meisel, R. [5 ]
机构：
[1] Vertex Pharmaceut, Munich, Germany
[2] Vertex Pharmaceut Inc, Boston, MA USA
[3] IQVIA, Frankfurt, Germany
[4] Team Gesundheit Gesell Gesundheitsmanagement mbH, Essen, Germany
[5] Heinrich Heine Univ, Klin Padiat Onkol Hamatol & Klin Immunol, Dusseldorf, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1065
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [41] Frequent Vaso-occlusive Crises Alter Brain Network Connectivity in Patients with Sickle Cell Disease
    Ichesco, Eric
    Pucka, Andrew Q.
    Harris, Richard E.
    Wang, Ying
    JOURNAL OF PAIN, 2024, 25 (04): : 47 - 47
  • [42] PROPHYLAXIS OF SICKLE-CELL VASO-OCCLUSIVE CRISES WITH PIRACETAM
    SONNET, J
    GINI, EK
    CORNU, G
    ANNALES DE LA SOCIETE BELGE DE MEDECINE TROPICALE, 1985, 65 (01): : 77 - 84
  • [43] THE RELATIONSHIP BETWEEN VASO-OCCLUSIVE CRISES AND WORK PRODUCTIVITY IMPAIRMENT IN PATIENTS WITH SICKLE CELL DISEASE
    Rizio, A.
    Bhor, M.
    Lin, X.
    White, M. K.
    Paulose, J.
    Nandal, S.
    Halloway, R., I
    Bronte-Hall, L.
    VALUE IN HEALTH, 2019, 22 : S345 - S345
  • [44] Elimination of vaso-occlusive crises after exagamglogene autotemcel in patients with severe Sickle Cell Disease
    Meisel, R.
    Frangoul, H.
    Locatelli, F.
    Sharma, A.
    Bhatia, M.
    Molinari, L.
    Wall, D.
    Liem, R.
    Telfer, P.
    Shah, A.
    Cavazzana, M.
    Corbacioglu, S.
    Rondelli, D.
    Dedeken, L.
    Lobitz, S.
    de Montalembert, M.
    Steinberg, M.
    Walters, M.
    Imren, S.
    Shi, D.
    Bower, L.
    Simard, C.
    Zhang, L.
    Morrow, P. K.
    Hobbs, B.
    Grupp, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 99 - 100
  • [45] Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
    Chuka Udeze
    Kristin A. Evans
    Yoojung Yang
    Timothy Lillehaugen
    Janna Manjelievskaia
    Urvi Mujumdar
    Nanxin Li
    Biree Andemariam
    Advances in Therapy, 2023, 40 : 5130 - 5130
  • [46] Frequency of vaso-occlusive crises among patients with severe sickle cell disease receiving standard-of-care treatment
    Titievsky, Lina
    Manjelievskaia, Janna
    Ender, Katherine L.
    Shi, Daoyuan
    Lillehaugen, Timothy
    Beukelman, Timothy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 85 - 85
  • [47] OPTIMIZATION OF PAIN MANAGEMENT STRATEGIES IN CHILDREN WITH SICKLE CELL DISEASE AND VASO-OCCLUSIVE CRISES
    LeBlanc, Dana
    Velez, Maria
    Gardner, Renee
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 46 - 46
  • [48] Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital
    Raphael, Jean L.
    Kamdar, Aditi
    Beavers, M. Brooke
    Mahoney, Donald H.
    Mueller, Brigitta U.
    PEDIATRIC BLOOD & CANCER, 2008, 51 (01) : 82 - 85
  • [49] MODELLING LONG-TERM CLINICAL OUTCOMES OF PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN THE UNITED STATES
    Wang, J.
    Udeze, C.
    Ogunsile, F. J.
    Xie, Y.
    Mujumdar, U.
    Yang, H.
    Salcedo, J.
    Lopez, A.
    VALUE IN HEALTH, 2022, 25 (12) : S91 - S91
  • [50] Unraveling the Complexity of Vaso-Occlusive Crises in Sickle Cell Disease: Insights from a Resource-Limited Setting
    Kaponda, Ali
    Muya, Kalunga
    Panda, Jules
    Koto, Kodondi Kule
    Bonnechere, Bruno
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
12345